Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea · Delayed Price · Currency is KRW 11,910
-140 (-1.16%)
At close: Apr 29, 2026
Biodyne Market Cap
Biodyne has a market cap or net worth of 347.05 billion as of April 30, 2026. Its market cap has decreased by -2.18% in one year.
Market Cap
347.05B
Enterprise Value
327.40B
Revenue
4.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,910.00
Market Cap Chart
Since March 17, 2021, Biodyne's market cap has increased from 252.12B to 347.05B, an increase of 37.66%. That is a compound annual growth rate of 6.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 347.05B | -13.63% |
| Dec 30, 2025 | 401.82B | -16.15% |
| Dec 30, 2024 | 479.20B | 19.24% |
| Dec 28, 2023 | 401.88B | 185.76% |
| Dec 29, 2022 | 140.63B | -31.74% |
| Dec 30, 2021 | 206.02B | -18.28% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Livsmed | 1.81T |
| Curiox Biosystems | 1.75T |
| RecensMedical | 347.21B |
| M.I.TECH Co.,Ltd | 214.24B |
| Synergy Innovation | 188.99B |
| Celemics | 130.63B |
| BIOBIJOU | 129.08B |
| Corentec | 76.33B |